Melanocyte-stimulating hormone release inhibiting factor
Biological ActivityInhibitor of melanocyte-stimulating hormone (MSH) release. Blocks the release of α-MSH, increases brain dopamine levels and antagonizes physiological and behavioral opioid effects in vivo.
(Modifications: Gly-3 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and activity.
Kavaliers and Hirst
Brain Res., 1986;372:370
Synthetic melanocyte stimulating hormone release inhibiting factor (MIF). Part III: effect of L-prolyl-N-MthD.-leucyl-glycinamide and MIF on biogenic amine turnover.
Pugsley and Lippmann
Pharmacology of L-Prolyl-L-Leucyl-Glycinamide (PLG): a review.
Mishra et al.
Methods Find.Exp.Clin.Pharmacol., 1983;5:203
Pharmacological studies with a tripeptide, Prolyl-Leucyl Glycine amide.
Plotnikoff and Kastin
No product specific FAQs exist for this product, however you mayView all Peptide FAQs
Reviews for Melanocyte-stimulating hormone release inhibiting factor
There are currently no reviews for this product. Be the first to review Melanocyte-stimulating hormone release inhibiting factor and earn rewards!
Have you used Melanocyte-stimulating hormone release inhibiting factor?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image